Home

Stryker Corp (SYK)

394.03
+3.60 (0.92%)

Stryker Corporation is a leading medical technology company that specializes in designing, manufacturing, and marketing innovative products and services for healthcare professionals and patients

The company offers a diverse range of medical devices, including surgical equipment, orthopedic implants, neurotechnology, and surgery assistance products. Stryker focuses on advancing healthcare through cutting-edge technology and solutions that enhance patient care, improve surgical outcomes, and streamline hospital operations. With a commitment to innovation and quality, Stryker plays a pivotal role in the medical industry, helping healthcare providers deliver effective treatment and improve the quality of life for patients around the world.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close390.43
Open391.15
Bid393.95
Ask394.17
Day's Range390.00 - 397.56
52 Week Range314.93 - 406.19
Volume418,383
Market Cap148.59B
PE Ratio (TTM)43.93
EPS (TTM)9.0
Dividend & Yield3.200 (0.81%)
1 Month Average Volume1,522,996

News & Press Releases

A Glimpse Into The Expert Outlook On Stryker Through 14 Analystsbenzinga.com
Via Benzinga · January 29, 2025
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growthbenzinga.com
Wall Street analysts upgraded Stryker Corp (NYSESYK) after its Q4 report beat expectations, with strong sales and earnings growth projected for 2025.
Via Benzinga · January 29, 2025
Starbucks To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Via Benzinga · January 29, 2025
US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earningsbenzinga.com
U.S. stock futures were mixed ahead of the crucial earnings from key U.S. technology companies and the Fed's expected pause on rate cuts.
Via Benzinga · January 29, 2025
Stryker Earnings Report: Q4 Overviewbenzinga.com
Via Benzinga · January 28, 2025
Stryker Earnings Review: Q4 Summarybenzinga.com
Via Benzinga · January 28, 2025
Stryker Earnings Analysis: Q4 Recapbenzinga.com
Via Benzinga · January 28, 2025
Stryker Q4 Earnings Assessmentbenzinga.com
Via Benzinga · January 28, 2025
Stryker Undercuts Breakout On Sales Deal, Despite Quarterly Beatinvestors.com
Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal business.
Via Investor's Business Daily · January 28, 2025
Tesla, Starbucks And 3 Stocks To Watch Heading Into Wednesdaybenzinga.com
Via Benzinga · January 29, 2025
Insights into Stryker Q4 Earningsbenzinga.com
Via Benzinga · January 28, 2025
Earnings Summary: Stryker Q4benzinga.com
Via Benzinga · January 28, 2025
Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSESYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein’s decision follows an impressive 22-year career at Stryker. Preston Wells, who currently serves as Group CFO for Stryker’s Orthopaedics Group, will assume the role of Vice President, Chief Financial Officer effective April 1, 2025.
By Stryker Corporation · Via GlobeNewswire · January 28, 2025
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · January 17, 2025
How Is The Market Feeling About Stryker?benzinga.com
Via Benzinga · January 17, 2025
Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSESYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space, to create a newly formed company called VB Spine, LLC.
By Stryker Corporation · Via GlobeNewswire · January 28, 2025
Stryker reports 2024 operating results and 2025 outlook
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSESYK) reported operating results for the fourth quarter and full year of 2024:
By Stryker Corporation · Via GlobeNewswire · January 28, 2025
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSESYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the issued and outstanding shares of common stock of Inari Medical, Inc. NASDAQ: NARINASDAQNARI)
By Stryker Corporation · Via GlobeNewswire · January 17, 2025
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025investors.com
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.
Via Investor's Business Daily · January 13, 2025
Earnings Scheduled For January 28, 2025benzinga.com
Via Benzinga · January 28, 2025
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?benzinga.com
These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?
Via Benzinga · January 12, 2025
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Positionbenzinga.com
Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach.
Via Benzinga · January 7, 2025
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · January 7, 2025
Inari Medical Catapults 30% On Rumored Stryker Takeoverinvestors.com
Inari is best-known for its series of catheter-like devices that remove blood clots.
Via Investor's Business Daily · January 6, 2025
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Stryker (NYSESYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. NASDAQ: NARINASDAQNARI)
By Stryker Corporation · Via GlobeNewswire · January 6, 2025